Back to Trials
NCT06741527NARecruiting

Integrity Implant System Post Market Clinical Follow-Up Study

Anika Therapeutics, Inc.

Start Date

2/1/2025

Completion Date

10/1/2027

Summary

The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

Detailed Description

The Study Objective is to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair). The clinical success will be evaluated by absence of rotator cuff re-tear. Performance and clinical benefits will be evaluated by functional outcomes measured using standard scoring systems such as the American Shoulder and Elbow Surgeons Shoulder Score (ASES), Constant-Murley Score (CMS), Patient Satisfaction, EQ-5D-5L, Single Assessment Numeric Evaluation (SANE), Visual Analogue Scale (VAS) and rotator cuff repair outcomes measured using MRI evaluation for repair integrity, quality, tendon tissue thickness and regeneration. Safety of the Integrity Implant System will be assessed by monitoring the frequency and incidence of adverse events. The Primary Endpoint shall confirm the Performance of the Integrity Implant System when used for rotator cuff augmentation (with or without repair). Performance will be evaluated by an adequately powered analysis of retear rates seen by MRI at 12-months after surgery.

Eligibility Criteria

Age Range: 18 years to No maximum

1. At least 18 years of age 2. Able (with assistance from LAR, if necessary) to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures. 3. Able to complete all Patient Reported Outcome Measure (PROM) questionnaires. 4. Fully understands study requirements and able to return for all required follow-up visits and assessments. 5. Able to comply with all post-operative physician prescribed rehabilitation instructions. 6. Index shoulder rotator cuff tendon tear surgical access may be performed using mini-open, single-portal arthroscopic or multi-portal arthroscopic intervention 7. Meets all intended use and indications for use defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include: Index shoulder rotator cuff tendon tear needs management and protection from injury Index shoulder has no substantial loss of tendon tissue Index shoulder rotator cuff tendon tear footprint allows approximation of soft tissue and fixation of the Integrity Implant to tendon tissue using an Integrity Tissue Tack Index shoulder rotator cuff tendon tear footprint allows fixation of the Integrity Implant to bone using the Integrity Bone Staple Exclusion Criteria The subject exclusion criteria are as follows: 1. Medical condition that in the PI's opinion would place the subject at risk or interfere with the study 2. Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study) 3. Pregnant, breastfeeding, or plans to become pregnant during the study 4. History of poor compliance with medical treatment of any kind 5. Deemed contraindicated for MRI by the PI 6. Previous rotator cuff surgery (any type) on the index shoulder 7. Current instability of the index shoulder 8. Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length \>5cm) 9. Chondromalacia of index shoulder ≥ Grade 3 10. Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3 11. Insulin dependent Type I Diabetes 12. History of heavy smoking (≥ 1 pack per day) within last 6-months 13. History of auto-immune or immunodeficiency disorders 14. Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases) 15. Oral steroid use in the last 2-months or injectable steroid use in the last 3-months 16. History of cognitive or mental health status that interferes with study participation 17. Poor comprehension of English language 18. Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include: 18.1 Rotator cuff tendon tear is deemed irreparable by the PI 18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon 18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue 18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement 18.5 Presence of infection 18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period 18.7 Hypersensitivity to any of the Integrity Implant System components 18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation 18.9 Inadequate quality of bone for Integrity Bone Staple fixation

Interventions

DEVICE

Integrity Implant System

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Rotator Cuff Tears of the Shoulder

Locations

OrthoArizona

Gilbert, Arizona 85234

United States

Premier Orthopaedic Trauma Specialists, PMC

Pomona, California 91767

United States

Foundation for Orthopaedic Research and Education

Tampa, Florida 33607

United States

Harbin Clinic

Rome, Georgia 30165

United States

Central Indiana Orthopaedics

Fishers, Indiana 46037

United States

Towson Orthopaedic Associates/University of Maryland St. Joseph's Medical Center

Towson, Maryland 21204

United States

Virtua Health

Marlton, New Jersey 08053

United States

Steadman Hawkins Clinic of the Carolinas

Greenville, South Carolina 29615

United States

Campbell Clinic

Germantown, Tennessee 38138

United States